{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-058173","form_type":"8-K","ticker":"STAA","cik":"0000718937","company_name":"STAAR SURGICAL CO","filed_at":"2025-04-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.097388+00:00","generated_at":"2026-05-23T07:31:08.874882+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"STAAR Surgical board reshuffles; Silverman rejoins, Weisner exits, Jiang takes APAC strategy role with $1.275M RSUs","bullets":["Louis Silverman reappointed to board effective April 24, 2025; board expands to 7 members.","Director Aimee Weisner will not stand for re-election at June 2025 annual meeting; board to shrink to 6.","Wei Jiang becomes Chief of APAC Strategy under consulting agreement through fiscal 2025, receiving RSUs valued at $1.275M.","CEO cites China distribution challenges, pre-tariff inventory at distributors, consignment agreements, and Swiss production ramp-up.","Company emphasizes cost control and improving profitability; earnings call expected in May 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-058173","json":"https://secwatch.observer/filing/0000950170-25-058173.json","markdown":"https://secwatch.observer/filing/0000950170-25-058173.md","text":"https://secwatch.observer/filing/0000950170-25-058173.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/718937/000095017025058173/0000950170-25-058173-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/718937/000095017025058173/staa-20250424.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T07:31:08.874882+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"06a756f8cb","claim":"Aimee S. Weisner departed as director at STAAR SURGICAL CO.","evidence_excerpt":"Ms. Weisner notified the Company that she has chosen not to stand for re-election when her term expires at the 2025 Annual Meeting","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/718937/000095017025058173/0000950170-25-058173-index.htm","confidence":0.9,"family_label":"Executive change","details":[{"label":"Action","value":"not stand for re-election"},{"label":"Role","value":"director"}],"fact_type":"executive_change"},{"claim_id":"8a3537a3ec","claim":"Wei Jiang was appointed as Chief of APAC Strategy at STAAR SURGICAL CO.","evidence_excerpt":"the Company entered into a consulting agreement with Mr. Jiang to serve as a special strategic advisor to the Company’s Asia Pacific business through the end of fiscal 2025, in the temporary role of Chief of APAC Strategy","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/718937/000095017025058173/0000950170-25-058173-index.htm","confidence":0.9,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief of APAC Strategy"}],"fact_type":"executive_change"},{"claim_id":"bde4c2954c","claim":"Louis E. Silverman was appointed as director at STAAR SURGICAL CO.","evidence_excerpt":"the Board appointed Louis E. Silverman, who served on the Company’s Board from 2014-2022, as a director, effective April 24, 2025","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/718937/000095017025058173/0000950170-25-058173-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}